Delivering a connection-building protein to star-shaped cells in the brain could reverse changes to neural circuits seen in Down syndrome, according to new research my colleagues and I published in the journal Cell Reports.
Down syndrome is caused by an error in cell division during development. Individuals receive three copies of chromosome 21 instead of the typical two copies, resulting in duplicates of the genes encoded on chromosome 21. This trisomy leads to a multitude of changes to heart and immune function as well as neurodevelopmental impairments.
Changes to the structure of neurons in people with Down syndrome alter how they connect with each other. One major type of brain cell called astrocytes helps form connections between neurons. These star-shaped cells have many thin arms that extend into the spaces between neurons. They also secrete various proteins that are vital to forming the proper neural connections necessary for brain function.
Researchers have found that mouse models of several neurodevelopmental disorders, including Down syndrome, have altered levels of astrocyte proteins during development. My colleagues and I hypothesized that these changes might contribute to the changes in neural connections seen in Down syndrome. Could restoring the proper levels of some of these astrocyte proteins “rewire” the brain?
Identifying an astrocyte protein
First, we needed to pick a candidate astrocyte protein to test our hypothesis. A previous study had identified a list of astrocyte proteins that were altered in a mouse model of Down syndrome. We focused on proteins present in lower levels in Down syndrome astrocytes compared to astrocytes without the condition. We thought there might not be enough of these proteins available to help form neural connections.
Among the top 10 proteins we identified was a molecule called pleiotrophin, or Ptn. This protein is known to help guide axons – long extensions that neurons use to send information to each other – to their targets during development. So it made sense that it might also help neurons form the branching arms they use to receive information.
We found that mice unable to produce Ptn had neurons with fewer branching arms, similar to what we saw in mice with Down syndrome. This correlation implies that proper Ptn levels are necessary to affect neuron branching during brain development.
Restoring neurons in Down syndrome
Next, we wanted to know if delivering Ptn to astrocytes changes neural connections in mice with Down syndrome.
To answer that question, we packaged the gene for Ptn into a small virus with its replication genes removed. Called adeno-associated viruses, these tools allow researchers to deliver genetic material to specific targets in the body and are used for applications like gene therapy. We delivered the Ptn gene into astrocytes throughout the entire brain of adult mice with Down syndrome so we could evaluate its effects.
We focused on the visual cortex and the hippocampus, areas of the brain involved in vision and memory that are both critically affected in Down syndrome. After enhancing the ability of astrocytes to produce Ptn, we found that both regions recovered levels of neural branching density similar to those of mice without Down syndrome.
Finally, we wanted to see if we could actually restore electrical activity levels in the hippocampus by increasing astrocyte Ptn levels. Measuring electrical activity can indicate whether neurons are functioning properly. After delivering the Ptn gene to the astrocytes of mice with Down syndrome, we found the electrical activity of their hippocampus restored to levels no different from mice without Down syndrome.
Together, our findings show that delivering Ptn to the astrocytes of mice can reverse changes to neuron structure and function seen in Down syndrome. While our findings are far from ready to be used in the clinic, more research could help us understand whether and how Ptn could help improve the health of human patients.
Rewiring the brain
More broadly, our findings suggest that astrocyte proteins have the potential to rewire the brain in other neurodevelopmental conditions.
Typically, adult brains have low plasticity, meaning they have a decreased capacity to form new connections between neurons. This means it can be difficult to change neural circuits in adults. Our hope is that further exploration on how astrocyte proteins can alter the adult brain could lead to new treatments for neurodevelopmental disorders like Fragile X syndrome or Rett syndrome, or to neurodegenerative diseases like Parkinson’s disease.
This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Ashley Brandebura, University of Virginia
Read more:
Ashley Brandebura receives funding from NIH NINDS and NIA.
